The SCCS adopted the final opinion on Kojic Acid at its plenary meeting on 15–16 March 2022. The final opinion was subject to a corrigendum adopted by the SCCS on 10 June 2022. The corrigendum includes changes in the calculation of systemic exposure dose, safety assessment, and conclusion.
This content is only available to Premium Members.
Get access to all our Premium content and services.
Start your Free Trial or Discover our plans.
Already a Premium member? Sign In
